Logo Image
|Articles|April 22, 2020

Next-Generation Biopharmaceutical Development Services

Catalent Biologics is a global leader in biopharmaceutical development services, bringing next-generation therapies to the market.

Catalent Biologics is a global leader in biopharmaceutical development  services, bringing next-generation therapies to the market. Its recent  acquisitions of Paragon Bioservices and MaSTherCell have expanded  its service portfolio to include development and manufacturing of cell  and gene therapies, alongside new biological entities, biosimilars, sterile injectables, and antibody-drug conjugates.

 

 INTERPHEX Booth # 1147

 

Catalent Pharma Solutions
14 Schoolhouse Road Somerset, NJ 08873, USA
solutions@catalent.comwww.catalent.com/biologics
tel. +1.888.765.8846

 

Related to this article

View more
Complying with International Pharmacopoeias
Complying with International Pharmacopoeias
Susan J. Schniepp, distinguished fellow with Nelson Labs, and Siegfried Schmitt, PhD, vice president, Technical, with Parexel, clear up some of the confusion about what does and does not need to be complied with regarding standards set by international pharmacopoeias.
Read more
CPHI Milan 2026: Nitrosamine Risk Mitigation, Part 2
CPHI Milan 2026: Nitrosamine Risk Mitigation, Part 2
Mitigating nitrosamine risk requires assessing each product individually, says Bram Baert, Global Head of Regulatory Affairs at Capsugel, and Sandrine Picco, Senior Analytical Specialist on Capsugel's Innovaform Accelerator Team, in this interview with PharmTech.
Read more
Trophy and confetti on light background, top view with space for text. Victory concept | Image Credit: ©New Africa -stock.adobe.com
Winners of the 2026 CPHI Pharma Awards Announced
The winners of the CPHI Pharma Awards 2026 include a neurodegeneration platform, a track-and-trace packaging innovation, a enzymatic mRNA manufacturing technology, and a cell-free enzymatic biomanufacturing platform.
Read more